BHC Stock: Price, Earnings History and SEC Filings
Bausch Health Companies Inc. (BHC) last traded at $8.20, down 7.97% on the latest session and up 40.7% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.77 against an analyst estimate of $1.08, a beat of 63.9%.
$8.20 -7.97%
1 month+40.65%
52-week high$9.04
52-week low$4.33
Volume8.64M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BHC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.77 | $1.08 | +63.89% |
| Jun 2026 | Jul 29, 2026 | $1.26 | $0.96 | +31.25% |
| Mar 2026 | Apr 29, 2026 | $0.78 | $0.81 | -3.70% |
| Dec 2025 | Feb 18, 2026 | $1.08 | $1.21 | -10.74% |
BHC beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
BHC financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $10.3B | $157M | $1.0B | 1.5% | $0.42 |
| 2024 | $9.6B | -$46M | $1.3B | -0.5% | $-0.13 |
| 2023 | $8.8B | -$592M | $817M | -6.8% | $-1.62 |
| 2022 | $8.1B | -$225M | -$946M | -2.8% | $-0.62 |
| 2021 | $8.4B | -$948M | $1.2B | -11.2% | $-2.64 |
| 2020 | $8.0B | -$560M | $809M | -7.0% | $-1.58 |
| 2019 | $8.6B | -$1.8B | $1.2B | -20.8% | $-5.08 |
| 2018 | $8.4B | – | $1.3B | – | $-11.81 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BHC
SEC filing data is not available right now. You can search for BHC on SEC EDGAR.
BHC news
- Up 55% in October: Is Bausch Health’s turnaround just getting started?Oct 30, 2026 · finance.yahoo.com
- BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook RisesOct 29, 2026 · finance.yahoo.com
- Bausch Health Companies Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- Bausch Health signals 2026 revenue of $5.525B-$5.625B as it outlines Q4 Xifaxan headwindsOct 29, 2026 · seekingalpha.com
- What Bausch Health Cos (BHC) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- Bausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesOct 28, 2026 · finance.yahoo.com
- Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to SayOct 28, 2026 · finance.yahoo.com
- Bausch: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
About Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) is a US-listed public company on NYSE.